TA
ZBH icon

Tamarack Advisers’s Zimmer Biomet ZBH Stock Holding History

Tamarack Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-128,750
Closed -$18.6M – 38
2019
Q4 		$18.6M Sell
128,750
-36,050
-22% -$4.98M 4.25% 9
2019
Q3 		$22M Buy
164,800
+72,100
+78% +$9.31M 5.72% 6
2019
Q2 		$10.9M Buy
+92,700
New +$10.9M 3.3% 13

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tamarack Advisers's ZBH Position: Q1 2020 in Review

Tamarack Advisers sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 128,750 shares — an estimated $18.6M sold.

Tamarack Advisers first reported a position in ZBH in Q2 2019 and held it in 3 quarters. The position peaked at $22M in Q3 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Tamarack Advisers reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Tamarack Advisers sold 128,750 Zimmer Biomet shares in Q1 2020, an estimated $18.6M.
  • Tamarack Advisers first reported a position in Zimmer Biomet in Q2 2019 and held it in 3 quarters.
  • Tamarack Advisers's Zimmer Biomet position peaked at $22M in Q3 2019.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Tamarack Advisers's 13F filing for Q1 2020, filed 14 May 2020.